InsiderTrades.com logo

ONCY Insider Trading

Insider Ownership Percentage: 0.10%
Insider Buying (Last 12 Months): $348,083.56
Insider Selling (Last 12 Months): $0.00

Oncolytics Biotech Insider Trading History Chart

This chart shows the insider buying and selling history at Oncolytics Biotech by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Oncolytics Biotech Share Price & Price History

Current Price: $1.02
Price Change: ▼ Price Decrease of -0.04 (-3.77%)
As of 03/10/2026 05:00 PM ET

This chart shows the closing price history over time for ONCY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Oncolytics Biotech Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/12/2026Allison HagermanVPBuy10,000$0.83$8,300.00115,059View SEC Filing Icon  
2/12/2026Bernd R SeizingerDirectorBuy40,000$0.85$34,000.00566,991View SEC Filing Icon  
2/12/2026Deborah Margaret BrownDirectorBuy25,000$0.85$21,250.00109,851View SEC Filing Icon  
2/12/2026Jared KellyCEOBuy29,500$0.84$24,780.00109,000View SEC Filing Icon  
2/12/2026Kirk LookCFOBuy12,000$0.84$10,080.00287,515View SEC Filing Icon  
2/12/2026Patricia S AndrewsDirectorBuy35,400$0.86$30,444.0078,128View SEC Filing Icon  
2/12/2026Thomas Charles HeinemanInsiderBuy12,132$0.83$10,069.56282,818View SEC Filing Icon  
2/12/2026Wayne PisanoDirectorBuy30,000$0.84$25,200.00492,414View SEC Filing Icon  
2/11/2026Andrew AromandoInsiderBuy29,600$0.86$25,456.0055,100View SEC Filing Icon  
2/11/2026Bernd R SeizingerDirectorBuy60,000$0.83$49,800.00526,991View SEC Filing Icon  
2/11/2026Jared KellyCEOBuy5,600$0.84$4,704.0079,500View SEC Filing Icon  
1/16/2026Bernd R SeizingerDirectorBuy100,000$1.04$104,000.00466,991View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Oncolytics Biotech (NASDAQ:ONCY)

6.82% of Oncolytics Biotech stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ONCY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Oncolytics Biotech Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026Virtu Financial LLC77,883$68K0.0%N/A0.073%Search for SEC Filing on Google Icon
2/19/2026Connective Capital Management LLC150,340$0.13M0.1%N/A0.142%Search for SEC Filing on Google Icon
2/18/2026XTX Topco Ltd78,661$69K0.0%N/A0.074%Search for SEC Filing on Google Icon
2/17/2026Blair William & Co. IL31,467$28K0.0%N/A0.030%Search for SEC Filing on Google Icon
2/13/2026Security National Bank of Sioux City Iowa IA33,255$29K0.0%N/A0.031%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP262,170$0.23M0.0%-19.1%0.247%Search for SEC Filing on Google Icon
2/12/2026Tocqueville Asset Management L.P.72,000$63K0.0%N/A0.068%Search for SEC Filing on Google Icon
2/12/2026CIBC Private Wealth Group LLC50,000$44K0.0%N/A0.047%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.169,899$0.15M0.0%-18.6%0.160%Search for SEC Filing on Google Icon
2/4/2026Ground Swell Capital LLC34,398$30K0.1%N/A0.032%Search for SEC Filing on Google Icon
11/17/2025Scientech Research LLC18,204$25K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Citadel Advisors LLC382,051$0.54M0.0%N/A0.381%Search for SEC Filing on Google Icon
8/12/2025Seeds Investor LLC223,767$0.17M0.0%+17.8%0.230%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC66,939$61K0.0%+59.6%0.084%Search for SEC Filing on Google Icon
2/12/2025National Bank of Canada FI64,479$60K0.0%+199.6%0.081%Search for SEC Filing on Google Icon
2/11/2025Virtu Financial LLC98,452$90K0.0%N/A0.123%Search for SEC Filing on Google Icon
1/24/2025Vantage Point Financial LLC29,744$27K0.0%N/A0.037%Search for SEC Filing on Google Icon
1/8/2025International Assets Investment Management LLC200,400$0.19M0.0%+15.0%0.259%Search for SEC Filing on Google Icon
10/22/2024International Assets Investment Management LLC174,331$0.15M0.0%-12.1%0.228%Search for SEC Filing on Google Icon
5/20/2024Virtu Financial LLC51,889$55K0.0%N/A0.068%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC269,699$0.36M0.0%+33.9%0.362%Search for SEC Filing on Google Icon
1/12/2024Advisor Resource Council100,000$0.14M0.0%N/A0.134%Search for SEC Filing on Google Icon
1/11/2024Ausdal Financial Partners Inc.30,000$40K0.0%+50.0%0.041%Search for SEC Filing on Google Icon
11/8/2023Ausdal Financial Partners Inc.20,000$44K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/13/2023Brave Asset Management Inc.25,000$55K0.0%+150.0%0.035%Search for SEC Filing on Google Icon
10/10/2023International Assets Investment Management LLC201,453$0.45M0.0%+3.3%0.278%Search for SEC Filing on Google Icon
10/4/2023International Assets Investment Management LLC201,453$0.45M0.0%+3.3%0.278%Search for SEC Filing on Google Icon
8/23/2023Headinvest LLC11,534$30K0.0%N/A0.016%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can32,380$85K0.0%N/A0.049%Search for SEC Filing on Google Icon
7/24/2023Brave Asset Management Inc.10,000$26K0.0%N/A0.015%Search for SEC Filing on Google Icon
7/20/2023International Assets Investment Management LLC194,963$0.51M0.1%+3.4%0.297%Search for SEC Filing on Google Icon
2/7/2023Lynwood Capital Management Inc.25,000$41K0.0%N/A0.041%Search for SEC Filing on Google Icon
1/24/2023International Assets Investment Management LLC169,111$0.61M0.1%-6.9%0.276%Search for SEC Filing on Google Icon
1/20/2023Newman Dignan & Sheerar Inc.18,915$31K0.0%+46.5%0.031%Search for SEC Filing on Google Icon
8/11/2022Toronto Dominion Bank35,362$34K0.0%N/A0.061%Search for SEC Filing on Google Icon
7/27/2022Advisor Resource Council100,000$0.10M0.0%N/A0.173%Search for SEC Filing on Google Icon
2/14/2022Long Focus Capital Management LLC40,000$56K0.0%N/A0.073%Search for SEC Filing on Google Icon
2/11/2022Advisor Resource Council100,000$0.14M0.0%N/A0.182%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Oncolytics Biotech logo
Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. It has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep, as well as with Roche Holding AG. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Read More on Oncolytics Biotech

Today's Range

Now: $1.02
Low: $1.01
High: $1.08

50 Day Range

MA: $1.01
Low: $0.83
High: $1.27

52 Week Range

Now: $1.02
Low: $0.33
High: $1.51

Volume

1,017,818 shs

Average Volume

1,470,646 shs

Market Capitalization

$108.27 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Who are the company insiders with the largest holdings of Oncolytics Biotech?

Oncolytics Biotech's top insider shareholders include:
  1. Bernd R Seizinger (Director)
  2. Wayne Pisano (Director)
  3. Kirk Look (CFO)
  4. Thomas Charles Heineman (Insider)
  5. Allison Hagerman (VP)
  6. Deborah Margaret Brown (Director)
  7. Jared Kelly (CEO)
  8. Patricia S Andrews (Director)
  9. Andrew Aromando (Insider)
Learn More about top insider investors at Oncolytics Biotech.

Who are the major institutional investors of Oncolytics Biotech?

Oncolytics Biotech's top institutional shareholders include:
  1. Marshall Wace LLP — 0.25%
  2. Goldman Sachs Group Inc. — 0.16%
  3. Connective Capital Management LLC — 0.14%
  4. XTX Topco Ltd — 0.07%
  5. Virtu Financial LLC — 0.07%
  6. Tocqueville Asset Management L.P. — 0.07%
Learn More about top institutional investors of Oncolytics Biotech stock.

Which major investors are selling Oncolytics Biotech stock?

Within the last quarter, ONCY stock was sold by these institutional investors:
  1. Marshall Wace LLP
  2. Goldman Sachs Group Inc.

Which major investors are buying Oncolytics Biotech stock?

During the previous quarter, ONCY stock was bought by institutional investors including:
  1. Connective Capital Management LLC
  2. XTX Topco Ltd
  3. Virtu Financial LLC
  4. Tocqueville Asset Management L.P.
  5. CIBC Private Wealth Group LLC
  6. Ground Swell Capital LLC
  7. Security National Bank of Sioux City Iowa IA
  8. Blair William & Co. IL
In the last year, these company insiders have bought Oncolytics Biotech stock:
  1. Bernd R Seizinger (Director)
  2. Wayne Pisano (Director)
  3. Kirk Look (CFO)
  4. Thomas Charles Heineman (Insider)
  5. Allison Hagerman (VP)
  6. Deborah Margaret Brown (Director)
  7. Jared Kelly (CEO)
  8. Patricia S Andrews (Director)
  9. Andrew Aromando (Insider)
Learn More investors buying Oncolytics Biotech stock.